Donor Cell-Derived Acute Myeloid Leukaemia with 3q26.2 Involvement/MECOM Rearrangement ‐ A Case Report and Literature Review
Open Access
- 7 December 2020
- journal article
- Published by LIDSEN Publishing Inc in OBM Transplantation
- Vol. 04 (04) , 1-11
Abstract
Donor cell-derived leukaemia (DCL) is an uncommon complication of allogeneic hematopoietic stem cell transplantation (HSCT). DCL might represent up to 5% of the post-HSCT disease relapses, but case numbers reported in the literature might underestimate the frequency. The leukemogenesis of DCL is not well understood due to the limited numbers of cases reported and lack of detailed molecular genetic information from recipients and donors. Although many theories have been proposed for leukemogenesis of DCL, the underlying molecular genetic mechanism are likely heterogeneous. Here we report a case of donor cell-derived acute myeloid leukaemia with 3q26.2 involvement/MECOM rearrangement and chromosome 20q deletion. We also reviewed the literature of previously described DCL cases, and we discussed the risk factors that might be important to the onset of DCL.Keywords
This publication has 28 references indexed in Scilit:
- Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived LeukemiaStem Cell Reports, 2020
- Hereditary Predisposition to Hematopoietic NeoplasmsMayo Clinic Proceedings, 2020
- Clonal dominance of a donor‐derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)Journal of Clinical Laboratory Analysis, 2019
- Hereditary myeloid malignanciesBest Practice & Research Clinical Haematology, 2019
- Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrationsCancer Genetics, 2019
- Donor Cell–Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic ReviewTransplantation and Cellular Therapy, 2018
- Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional AbnormalityTransplantation and Cellular Therapy, 2017
- Breakpoint heterogeneity in (2;3)(p15–23;q26) translocations involving EVI1 in myeloid hemopathiesBlood Cells, Molecules, and Diseases, 2015
- Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cellsLeukemia Research Reports, 2014
- Donor Cell Leukemia: A ReviewTransplantation and Cellular Therapy, 2011